BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2737129)

  • 1. [Effect of surgical treatment on the natural killer activity in lung cancer patients].
    Ancheva M; Boeva M; Tenev V
    Eksp Onkol; 1989; 11(2):39-41. PubMed ID: 2737129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the decreased NK (natural killer) activity in lung cancer patients, using whole blood versus separated mononuclear cells.
    Nielsen LR; Kimose HH; Linnet L; Møller NP; Bukh A
    J Clin Lab Immunol; 1989 Jun; 29(2):71-7. PubMed ID: 2632804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant drugs increase natural killer cell activity in lung cancer.
    Bobek V; Boubelik M; Fiserová A; L'uptovcová M; Vannucci L; Kacprzak G; Kolodzej J; Majewski AM; Hoffman RM
    Lung Cancer; 2005 Feb; 47(2):215-23. PubMed ID: 15639720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
    Uchida A; Kolb R; Micksche M
    J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lysosomal enzymes and natural killer activity].
    Bulychev AG; Blinova TV
    Tsitologiia; 1991; 33(2):76-9. PubMed ID: 1926574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of C-reactive protein on natural killer activity].
    Shibuya M; Saijo N; Shimizu E; Taniguchi T; Takizawa T; Fujioka H; Hoshi A
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2341-6. PubMed ID: 6639096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytotoxic activity of autologous lymphocytes against lung cancer cells; correlation of prognosis and recurrence pattern].
    Kimura H; Yamaguchi Y
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2885-9. PubMed ID: 3499120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prognostic effect of natural killer cell infiltration to tumoral tissues in stage I non-small cell lung cancer].
    Karadayi S; Kayi Cangir A; Ozturk S; Dizbay Sak S; Akal M; Akay H
    Tuberk Toraks; 2008; 56(3):251-6. PubMed ID: 18932025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
    Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H
    Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.
    Balch CM; Tilden AB; Dougherty PA; Cloud GA; Abo T
    Surgery; 1984 Jan; 95(1):63-70. PubMed ID: 6581546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of natural killer cell activity by serum from cancer patients: preliminary results of a study of patients with colorectal adenocarcinoma or other types of cancer.
    Pislarasu M; Oproiu A; Taranu D; Herberman RB; Sulica A
    Cancer Res; 1988 May; 48(9):2596-603. PubMed ID: 3356020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased response to interleukin-2 of cancer patients in terms of augmentation of natural killer cell activity.
    Abe Y; Ajitsu S; Hamuro J; Ishikawa M; Sendo F
    Jpn J Cancer Res; 1985 Oct; 76(10):1003-7. PubMed ID: 3935618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption.
    Laso FJ; Madruga JI; Girón JA; López A; Ciudad J; San Miguel JF; Alvarez-Mon M; Orfao A
    Hepatology; 1997 May; 25(5):1096-100. PubMed ID: 9141423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer].
    Sakamoto M; Mikasa K; Hamada K; Konishi M; Maeda K; Yoshimoto E; Ueda K; Majima T; Sawaki M; Kita E; Narita N
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2259-66. PubMed ID: 9881083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
    Jezewska E; Björkholm M; Giscombe R; Holm G; Tullgren O
    Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social support, psychological distress, and natural killer cell activity in ovarian cancer.
    Lutgendorf SK; Sood AK; Anderson B; McGinn S; Maiseri H; Dao M; Sorosky JI; De Geest K; Ritchie J; Lubaroff DM
    J Clin Oncol; 2005 Oct; 23(28):7105-13. PubMed ID: 16192594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cell function in trisomy-21 (Down's syndrome).
    Nurmi T; Huttunen K; Lassila O; Henttonen M; Säkkinen A; Linna SL; Tiilikainen A
    Clin Exp Immunol; 1982 Mar; 47(3):735-41. PubMed ID: 6177458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Post-operative suppression of natural killer activity].
    Tanaka N; Yoshihara H; Ono M; Moritani T; Terasawa A; Beika T; Mannami T; Konaga E; Mimura H; Kunzo O
    Nihon Geka Gakkai Zasshi; 1983 Mar; 84(3):203-10. PubMed ID: 6674793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defects in natural killer cell activity and interferon response in human lung carcinoma and malignant melanoma.
    Sibbitt WL; Bankhurst AD; Jumonville AJ; Saiki JH; Saiers JH; Doberneck RC
    Cancer Res; 1984 Feb; 44(2):852-6. PubMed ID: 6198076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.